Is your child currently experiencing moderate to severe CD flare-ups? Local Crohn’s disease medical research study is testing a potential new medication to see if it may reduce abdominal pain and cramps, fatigue, constant need to poop, malnutrition, and/or liver disease associated with moderate to severe CD.
If you’re concerned about how moderate to severe CD affects your child’s life, find out more about the Crohn’s disease medical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrollment is limited, so please respond now.

We are looking for children 2 to 17 years of age to join a CD trial to help us discover more about treating ulcerative colitis. If you are looking for a potential new treatment option for ulcerative colitis or moderately to severely active IBD (including associated symptoms such as joint pain, blood in the stool, rectal pain, chronic fatigue and/or joint pain), consider one of our clinical research. All eligible participants will receive no-cost study-related care and study medication. Your children 2 to 17 years of age may be eligible to take part.

Your child may be eligible to take part in the clinical research if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child qualifies.

We are looking for young people aged 2 to 17 years to join a Crohn’s disease (CD) research to help us discover more about treating ulcerative colitis. If you are looking for a potential new treatment option for ulcerative colitis or CD (including associated symptoms such as fever, diarrhea, diarrhea, weight loss and/or eye pain), consider one of our studies. All eligible participants will receive no-cost study-related care and study medication. Your young people aged 2 to 17 years may be eligible to take part.

Your child may be eligible to take part in the studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrollment is limited, so please respond now.

Is your child currently experiencing ulcerative colitis (UC) flare-ups? Local Crohn’s disease (CD) research study is testing a potential new medication to see if it may reduce diarrhea, iron deficiency, cramps, malnutrition, and/or joint pain associated with ulcerative colitis (UC).
If you’re concerned about how ulcerative colitis (UC) affects your child’s life, find out more about the Crohn’s disease (CD) research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child qualifies.

We are looking for children at least 2 years of age but under 18 to join a Crohn’s disease (CD) research to help us discover more about treating CD and UC. If you are looking for a potential new treatment option for CD and UC or moderate to severe Crohn’s disease (including associated symptoms such as diarrhea with blood, blood in the stool, bloody stool, malnutrition and/or eye pain), consider one of our clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your children at least 2 years of age but under 18 may be eligible to take part.

Your child may be eligible to take part in the clinical trials if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Is your child eligible?

Is your child currently experiencing CD flare-ups? Local Crohn’s disease (CD) research study is testing a potential new medication to see if it may reduce fatigue, fatigue, constant need to poop, weight loss, and/or joint pain associated with CD.
If you’re concerned about how CD affects your child’s life, find out more about the Crohn’s disease (CD) research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Act now.

Is your child currently experiencing IBD flare-ups? Local Crohn’s disease (CD) clinical research study is testing a potential new medication to see if it may reduce joint pain, failure to thrive, bloody stool, weight loss, and/or eye pain associated with IBD.
If you’re concerned about how IBD affects your child’s life, find out more about the Crohn’s disease (CD) clinical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child is eligible.

We are looking for young people 2–17 years of age to join a Crohn’s disease (CD) research to help us discover more about treating CD and UC. If you are looking for a potential new treatment option for CD and UC or moderately to severely active ulcerative colitis (including associated symptoms such as painful joints, joint pain, rectal pain, weight loss and/or canker sores), consider one of our medical research studies. All eligible participants will receive no-cost study-related care and study medication. Your child or teen 2–17 years of age may be eligible to take part.

Your child may be eligible to take part in the medical research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

See if your child qualifies.

Is your child currently experiencing CD and UC flare-ups? Local study is testing a potential new medication to see if it may reduce diarrhea with pus, fever, abdominal pain, chronic fatigue, and/or eye pain associated with CD and UC.
If you’re concerned about how CD and UC affects your child’s life, find out more about the study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child qualifies.

Is your child currently experiencing moderately to severely active ulcerative colitis flare-ups? Local Crohn’s disease research is testing a potential new medication to see if it may reduce painful joints, diarrhea, bloody stool, frequent fevers, and/or liver disease associated with moderately to severely active ulcerative colitis.
If you’re concerned about how moderately to severely active ulcerative colitis affects your child’s life, find out more about the Crohn’s disease research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child is eligible.